Autres langues Balaxi Pharmaceuticals Limited

Actions

BALAXI

INE618N01022

Marché Fermé - NSE India S.E. Autres places de cotation 13:58:32 07/06/2024			Varia. 5j.	Varia. 1 janv.
113,6 ^INR	+6,71 %		-4,50 %	+31,43 %

29/05	Balaxi Pharmaceuticals Limited annonce ses resultats pour le quatrieme trimestre et l'exercice clos le 31 mars 2024	CI
09/05	Balaxi Pharmaceuticals Limited nomme Mahesh Inani au poste de Compliance Officer	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Balaxi Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	29/05
Balaxi Pharmaceuticals Limited Appoints Mahesh Inani as the Compliance Officer	09/05
Balaxi Pharmaceuticals Limited Announces Resignation of Purnima Singh Kamble as Independent Director	08/05
Balaxi Pharmaceuticals Limited Announces Resignation of Udayan Shukla as Company Secretary and Compliance Officer	04/05
Balaxi Pharmaceuticals Limited Incorporates New Wholly Owned Subsidiary in Chile	14/02
Balaxi Pharmaceuticals Limited Announces Update on Company's Pharmaceutical Formulation Plant	09/02
Balaxi Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	09/02
Balaxi Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	02/11
Balaxi Pharmaceuticals Limited completed the acquisition of Balaxi Healthcare Ecuador S.A.S.	01/10/23
Balaxi Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	03/08/23
Balaxi Pharmaceuticals Limited agreed to acquire Balaxi Healthcare Ecuador S.A.S. for $0.04 million.	03/08/23
Balaxi Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	29/05/23
Balaxi Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	01/02/23
Balaxi Pharmaceuticals : Certificate under SEBI (Depositories and Participants) Regulations, 2018	10/01/23
Balaxi Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	05/11/22
Balaxi Pharmaceuticals : Press Release	05/09/22
Balaxi Pharmaceuticals : Extra Ordinary Meeting	05/09/22
Balaxi Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	02/08/22
Balaxi Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2022	23/05/22
Balaxi Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	09/02/22

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Balaxi Pharmaceuticals Limited

Actions

BALAXI

INE618N01022

Autres langues

Filtres